设为首页 |  加入收藏
首页期刊介绍编委会投稿须知通知公告刊登文章继续教育园地协办单位联系我们广告合作
公告栏:
溴芬酸钠滴眼液在先天性白内障围手术期中的应用研究
作者:陈睛晶  林铎儒  林卓玲  李晓颜  吴晓航  林浩添  陈伟蓉 
单位:中山大学中山眼科中心, 眼科学国家重点实验室, 广东 广州 510060
关键词:溴芬酸钠 先天性白内障 围手术期 并发症 
中图分类号:R969.4
文献标志码:
出版年,卷(期):页码:2019,29(1):42-47,
收稿日期:2018-7-9
摘要:
目的 评估在先天性白内障围手术期使用溴芬酸钠滴眼液对减少术后短期炎症和高眼压的作用。方法 前瞻性随机对照研究。选取2016年4月~2017年4月就诊于中山大学中山眼科中心拟行白内障手术并符合入选标准的先天性白内障患儿分为研究组25例(34眼)及对照组29例(35眼)。对照组术后使用妥布霉素地塞米松滴眼液及眼膏,研究组术前术后联合使用溴芬酸钠滴眼液,同时减少妥布霉素地塞米松用量。通过观察两组术前、术后1周、术后1个月的炎症反应、角膜水肿、眼压和后发性白内障等并发症的组间对比(独立样本t检验),比较两组用药方案的疗效。结果 本研究共纳入54例患儿,其中研究组25例,对照组29例。研究组和对照组患儿的眼压(13.44±2.84及14.54±3.01 mmHg,p=0.123)和中央角膜厚度(554.88±49.42及576.91±49.08 μm,p=0.068)在术前差异无统计学意义。术后1周时,两组患儿眼压和中央角膜厚度均较术前明显上升,在术后1月下降。术后中央角膜厚度的变化差异无统计学意义。术后1周时,研究组眼压低于对照组(15.11±5.18及18.70±8.92 mmHg,p=0.045)。研究组和对照组在术后1周的高眼压患者(>21 mm Hg)比例分别为8.82%(3/34)和20.0%(7/35);术后1月的高眼压患者比例分别为2.94%(1/34)和5.71%(2/35)。研究组在术后的炎症反应和后发性白内障总分均低于对照组。结论 先天性白内障围手术期使用溴芬酸钠滴眼液可以有效降低术后炎症和并发症,是一种合理有效的用药方案。
OBJECTIVE To evaluate the effect of bromfenac sodium eye drops on postoperative short ̄term inflammation and ocular hypertension in patients with congenital cataract. METHODS A prospective randomized controlled study. From April 2016 to April 2017,54 children with congenital cataract from the Zhongshan Ophthalmic Center for cataract surgery were randomly divide into study group (24 cases with 34 eyes) and control group (29 cases with 35 eyes). In the control group,Tobramycin,Dexamethasone Ophthalmic Suspension and eye ointment were used after operation. The study group combined with bromfenac sodium eye drops before and after operation, and reduced the amount of tobramycin dexamethasone. The effects were compared between the two groups of complications such as inflammation,corneal edema,intraocular pressure,and posterior onset cataract (independent sample t test) before and after the operation,one week after operation,and one month after the operation. RESULTS There was no significant difference in intraocular pressure(13.44±2. 84 VS. 14. 54 ±3. 01mmHg,p=0. 123) and central corneal thickness (554. 88 ±49. 42 VS. 576. 91 ±49.08 μm,p=0. 068) between the study group and the control group before operation. At one week after operation,the intraocular pressure and central corneal thickness of the two groups increased significantly compared with those before operation,and decreased in one month after operation. There was no difference in central corneal thickness after surgery. One week after surgery,the intraocular pressure of the study group was lower than that of the control group (15.11±5.18 VS. 18.70±8.92 mmHg,p=0.045). The proportion of patients with high intraocular pressure (>21 mmHg) in the study group and the control group was 8.82% (3/34) vs. 20% (7/35), respectively,and 2.94% (1/34) vs. 5. 71% (2/35) after one month after operation,respectively. The total scores of inflammatory reaction and posterior capsule cataract in the study group were lower than those in the control group. CONCLUSION Bromfenac sodium eye drops during perioperative period of congenital cataract can effectively reduce postoperative inflammation and complications. It is a rational and effective medication regimen.
基金项目:
作者简介:
陈睛晶,主治医师,研究方向:白内障,Tel:18923130713,E-mail:34728424@qq.com
通讯作者:陈伟蓉,教授,主任医师,研究方向:白内障
参考文献:
[1] 刘奕志, 吴明星. 先天性白内障的手术治疗及展望[J]. 中国眼耳鼻喉科杂志, 2017, 17(2):79-81.
[2] Wang X J, Wong S H, Givergis R, et al. Evaluation of analgesic efficacy ofbromfenac sodium ophthalmic solution 0.09% versus ketorolac tromethamine ophthalmic solution 0. 5% following LASEK or EPILASIK[J]. Clin ophthalmol, 2011, 5:1451-1457.
[3] Xu Y, Zhao X, Zhang F J, et al. The clinical efficacy of 0.1% bromfenac sodium hydrate ophthalmic solution after excimer laser in situ keratomileusis[J]. Zhonghua Yan Ke Za Zhi, 2013, 49(4):320326.
[4] Kashiwagi K, Tsukahara S. Effect of non-steroidal anti-inflammatory ophthalmic solution on intraocular pressure reduction by latanoprost[J]. Br J Ophthalmol, 2003, 87(3):297-301.
[5] 赵家良, 黎晓新, 董东生, 等. 普拉洛芬滴眼液治疗白内障术后炎症和非感染性眼前段炎症的临床评价[J].眼科研究, 2000, 18(6):560-564.
[6] Aslam T M, Patton N. Methods of assessment of patients for Nd:YAG laser capsulotomy that correlate with final visual improvement[J]. BMC Ophthalmol, 2004, 23(4):13.
[7] Kruger A J, Amon M, Abela-Formanek C, et al. Postoperative inflammation after lens epihtelial cell removal 2 year results[J]. J Cataract Refract Surg, 2001, 27:1380-1385.
[8] 赵堪兴, 杨培增. 眼科学[M]. 北京:人民卫生出版社, 2008:241-2, 165, 309.
[9] 王慧涵, 梁宏元, 张丽华. 糖皮质激素对儿童生长发育及骨骼健康的影响[J]. 国外医学儿科, 2003, 30(5):279-280.
[10] Kim S J, Flach A J, Jampol L M. Nonsteroidal anti-inflammatory drugs in ophthalmology[J]. Surv Ophthalmol, 2010, 55(2):108133.
[11] Reddy M S, Suneetha N, Thomas R K, et al. Topical diclofenac sodium for treatment of postoperative inflammation in cataract surgery[J]. Indian J Ophthalmol, 2000, 48:223-226.
[12] Missotten L, Richard C, Trinquand C. Topical 0.1% indomethacin solution versus topical 0.1% dexamethasone solution in the Prevention of inflammation after cataract surgery[J]. Ophthalmologica, 2001, 215:43-50.
[13] Carreno E, Portero A, Galarreta D J, et al. Update on twice-daily bromfenacsodium sesquihydrate to treat postoperative ocular inflammation following cataract estraction[J]. Clin Ophthalmol, 2012, 6:637-644.
[14] Guex C Y. Non-steroidal anti-inflammatory drugs and ocular inflammation[J]. Klin Monbl Augenheilkd, 2001, 218(5):305-308.
[15] Perry H D, Donnenfeld E D. Bromfenac ophthalmic solution 0.09%:ocular role and systemic safety profile[J]. Expert Rev Ophthalmol, 2008, 3(2):121-129.
[16] McNamara T, Baklayan G A, Deshmukh H M, et al. Concentrations of radioactivity in ocular tissues following a single topical ocular dose of 14c-bromfenac ophthalmic solution(Xibrom)[J]. Invest Ophthalmol Vis Sci, 2006, 47:5086.
[17] Ogawa T, Miyake K, McNanara T R, et al. Pharmacokinetic profile of topically applied bromfenac sodium ophthalmic solution 0.1% in subjects undergoing cataract surgery[J]. Invest Ophthalmol Vis Sci, 2006, 47:687.
[18] Miyake K, Ogawa T, Tajika T, et al. Ocular pharmacokinetics of a single dose of bromfenac sodium ophthalmic solution 0.1% in human aqueous humor[J]. J Ocul Pharmacol Ther, 2008, 24(6):573-578.
[19] Lin H T, Chen W R, Luo L X, et al. Ocular Hypertension after Pediatric Cataract Surgery:Baseline Characteristics and First-Year Report[J]. PLoS one, 2013, 8(7):e69867.
服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
 
友情链接  
广东今日药学杂志社有限公司   地址:广州市东风东路753号东塔7楼702
电话:020-37886325       邮箱:jinriyaoxue@163.com
本系统由北京博思汇文数字科技有限公司设计开发 技术服务电话:400-921-9838
粤ICP备20054928号

粤公网安备 44010402002138号

您是第 165168 位访问者